Novabay Pharmaceuticals, Inc. approved to elect Mijia (Bob) Wu Class I directors nominated by the Company's Board of Directors to hold office for a term of three (3) years or until their respective successors are elected and qualified.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.44 USD | -5.68% | -25.43% | -51.82% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.82% | 3.96M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- NBY Stock
- News NovaBay Pharmaceuticals
- Novabay Pharmaceuticals, Inc. Approves to Elect Mijia Wu as Director